|
Womer, Karl L; Magee, Colm C; Najafian, Nader et al. (2008) A pilot study on the immunological effects of oral administration of donor major histocompatibility complex class II peptides in renal transplant recipients. Clin Transplant 22:754-9
|
|
Salama, Alan D; Najafian, Nader; Clarkson, Michael R et al. (2003) Regulatory CD25+ T cells in human kidney transplant recipients. J Am Soc Nephrol 14:1643-51
|
|
Kist-van Holthe, Joana E; Gasser, Martin; Womer, Karl et al. (2002) Regulatory functions of alloreactive Th2 clones in human renal transplant recipients. Kidney Int 62:627-31
|
|
Donato, Jose L; Ko, Jon; Kutok, Jeffery L et al. (2002) Human HTm4 is a hematopoietic cell cycle regulator. J Clin Invest 109:51-8
|
|
Najafian, Nader; Salama, Alan D; Fedoseyeva, Eugenia V et al. (2002) Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients. J Am Soc Nephrol 13:252-9
|
|
Frank, M H; Denton, M D; Alexander, S I et al. (2001) Specific MDR1 P-glycoprotein blockade inhibits human alloimmune T cell activation in vitro. J Immunol 166:2451-9
|
|
Stadlbauer, T H; Schaub, M; Magee, C C et al. (2000) Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways. J Heart Lung Transplant 19:566-75
|
|
Murphy, B; Magee, C C; Alexander, S I et al. (1999) Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis. J Clin Invest 103:859-67
|
|
Onodera, K; Chandraker, A; Volk, H D et al. (1999) Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2. Transplantation 68:288-93
|
|
Lara-Marquez, M L; Deykin, A; Krinzman, S et al. (1998) Analysis of T-cell activation after bronchial allergen challenge in patients with atopic asthma. J Allergy Clin Immunol 101:699-708
|
Showing the most recent 10 out of 40 publications
